Lanean...
Prospective Study of Efficacy and Safety of Lansoprazole in Zollinger-Ellison Syndrome
Lansoprazole, a new substituted benzimidazole H(+),K(+)-ATPase inhibitor, profoundly inhibits gastric acid secretion and has potential use in the management of diseases such as Zollinger-Ellison syndrome (ZES). In the present study we evaluated the efficacy and safety of lansoprazole in controlling...
Gorde:
| Argitaratua izan da: | Dig Dis Sci |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
1993
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721849/ https://ncbi.nlm.nih.gov/pubmed/8425437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/bf01307541 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|